Advancing cancer prevention and patient-centered care
The Alliance Cancer Control Program (CCP) serves as the Alliance’s National Cancer Institute Community Oncology Research Program (NCORP) Research Base, conducting interventional, methodological, and health policy research to reduce the incidence, morbidity, and mortality of cancer. The program examines factors that influence cancer risk and outcomes, identifies opportunities to prevent cancer and lessen the impact of cancer and its treatment, and develops approaches to improve quality of life for patients and survivors.
Integrating cancer control into clinical research
CCP researchers collaborate with Alliance programs and disease committees to incorporate cancer control research and relevant endpoints into clinical trials. These may include quality of life, patient-reported outcomes, symptom burden, treatment toxicity, economic impact, and other factors that reflect the patient’s experience.
The Alliance’s national network of academic and community sites provides opportunities to study varied populations, address barriers to prevention and care, and evaluate strategies. in real-world settings. Integrating cancer control research into large-scale clinical trials helps translate advances in cancer treatment into meaningful improvements in patients’ lives.
Addressing critical challenges
Across the cancer continuum, CCP research tackles complex scientific, clinical, and health care delivery challenges that shape how cancer is prevented, treated, and experienced by patients and communities. The program brings together seven specialized committees, each focused on a distinct area of cancer control:
- Cancer Care Delivery Research: Studies how cancer care is delivered and develops strategies to improve quality, access, coordination, and outcomes.
- Cancer in the Older Adult: Addresses the unique needs and treatment considerations of older adults with cancer.
- Community Oncology: Advances cancer research and clinical trial participation in community-based settings.
- Populations, Education, Access, and Research (PEAR): Examines factors that influence cancer risk, research participation, access to care, and outcomes across populations.
- Health Outcomes: Focuses on quality of life, patient-reported outcomes, and other measures that capture the patient experience.
- Prevention: Advances research to reduce cancer risk and prevent cancer across populations.
- Symptom Intervention: Develops and evaluates strategies to prevent and manage cancer- and treatment-related symptoms and side effects.
Principal Investigator and Director
Alliance Cancer Control Program
Electra Paskett, PhD
Marion N. Rowley Professor of Cancer Research
The Ohio State University College of Public Health